| Cat. No. |
Product Name |
Information |
| PC-28508 |
Brenipatide
GIP/GLP-1 agonist
|
Brenipatide (LY-3537031) is a potent, dual-agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, targets central nervous system and inflammatory pathways that include receptors linked to reward and addiction in the brain. |
| PC-28506 |
Anvoglutide
GLP-1 agonist
|
Anvoglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with antidiabetic and anti-obesity activity. |
| PC-28402 |
Liraglutide TFA
GLP-1 agonist
|
Liraglutide TFA (NN2211) is a long-acting GLP-1 analogue, glucagon-like peptide-1 (GLP-1) receptor agonist, induces lasting and reversible weight loss. |
| PC-28324 |
Tirzepatide hydrochloride
Dual GIP/GLP-1 agonist
|
Tirzepatide hydrochloride (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, binds both receptor with high affinity (GIPR Ki=0.135; GLP-1R Ki=4.23 nM). |
| PC-27516 |
Zormapatide
GIP receptor agonist
|
Zormapatide is a potent, selective gastric inhibitory polypeptide (GIP) receptor agonist with antidiabetic activity. |
| PC-27507 |
Tapimtrutide
GIP/GLP-1/GCGR agonist
|
Tapimtrutide is a potent triple glucagon, gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist. |
| PC-27455 |
Albiglutide TFA
GLP-1 agonist
|
Albiglutide TFA (GSK-716155) is a GLP-1 analog and long-acting, dipeptidyl peptidase-4-resistant GLP-1 receptor agonist, stimulates cAMP production through the GLP-1 receptor and induces insulin secretion from INS-1 cells in vitro and in animal models. |
| PC-27454 |
Albiglutide
GLP-1 agonist
|
Albiglutide (GSK-716155) is a GLP-1 analog and long-acting, dipeptidyl peptidase-4-resistant GLP-1 receptor agonist, stimulates cAMP production through the GLP-1 receptor and induces insulin secretion from INS-1 cells in vitro and in animal models. |
| PC-27453 |
Dulaglutide
GLP-1 agonist
|
Dulaglutide (LY2189265) is a long-acting glucagon-like peptide-1 analog and GLP-1 receptor agonist, shows full receptor activity in vitro and elicits insulinotropic activity in islets similar to native peptide, increases glucose tolerance. |
| PC-27415 |
Caroglipron
GLP-1R agonist
|
Caroglipron is a potent, selective glucagon-like peptide-1 receptor (GLP-1R) agonist. |
| PC-27411 |
Birmiglipron
GLP-1R agonist
|
Birmiglipron is a potent, selective glucagon-like peptide-1 receptor (GLP-1R) agonist. |
| PC-26956 |
Orforglipron hemicalcium hydrate
GLP-1R agonist
|
Orforglipron hemicalcium hydrate (LY3502970, OWL-833) is a potent, selective, orally active non-peptide agonist of glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) with Ki of 1 nM. |
